World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School
Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!
New Strategies For Cancer Vaccines: Transforming Cancer Cells So They Can Become Cancer-Fighters Is Not Far Away!
Imperial College Hospital
Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!
